{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/DMX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DMX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMX\",,,,,undefined,":{"symbol":"DMX","market":"US","secType":"STK","nameCN":"DoubleLine Multi-Sector Income ETF","latestPrice":50.6198,"timestamp":1770748632632,"preClose":50.55,"halted":0,"volume":5248,"delay":0,"changeRate":0.00138081107814047,"floatShares":1460001,"shares":1460001,"eps":0,"marketStatus":"Trading","change":0.0698,"latestTime":"02-10 13:51:00 EST","open":50.64,"high":50.67,"low":50.615,"amount":265743.08096,"amplitude":0.001088,"askPrice":50.69,"askSize":100,"bidPrice":50.57,"bidSize":198,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1770757200000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":50.55,"sharesOutstanding":1460001,"nav":50.4568,"aum":73667036.39,"dividendRate":0.05893,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":50.55,"preClose":50.55,"latestTime":"16:10 EST","volume":7,"amount":353.85,"timestamp":1770671404272,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.716741},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMX\",,,,,undefined,":{"symbol":"DMX","floatShares":1460001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.716741,"shares":1460001,"dividePrice":2.983,"high":50.67,"amplitude":0.001088,"preClose":50.55,"low":50.615,"week52Low":48.45,"pbRate":"--","week52High":50.87,"institutionHeld":0,"latestPrice":50.6198,"committee":0.328859,"eps":0,"divideRate":0.05893,"volume":5248,"delay":0,"ttmEps":0,"open":50.64,"prevYearClose":50.52,"prevWeekClose":50.56,"prevMonthClose":50.73,"prevQuarterClose":50.52,"fiveDayClose":50.47,"twentyDayClose":50.61,"sixtyDayClose":50.43},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DMX\",params:#limit:5,,,undefined,":[{"date":"2026-02-02","symbol":"DMX","amount":0.239201,"announcedDate":"2026-01-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-02-02","defaultRemindTime":1770042600000,"name":"DoubleLine Multi-Sector Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-06","payableDate":"2026-02-02","currency":"USD","dateTimestamp":1770008400000,"payDate":"2026-02-06"},{"date":"2025-12-01","symbol":"DMX","amount":0.248311,"announcedDate":"2025-11-28","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-01","defaultRemindTime":1764599400000,"name":"DoubleLine Multi-Sector Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-05","payableDate":"2025-12-01","currency":"USD","dateTimestamp":1764565200000,"payDate":"2025-12-05"},{"date":"2025-11-03","symbol":"DMX","amount":0.256654,"announcedDate":"2025-10-31","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-11-03","defaultRemindTime":1762180200000,"name":"DoubleLine Multi-Sector Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-11-07","payableDate":"2025-11-03","currency":"USD","dateTimestamp":1762146000000,"payDate":"2025-11-07"},{"date":"2025-10-01","symbol":"DMX","amount":0.263507,"announcedDate":"2025-09-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-10-01","defaultRemindTime":1759325400000,"name":"DoubleLine Multi-Sector Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-07","payableDate":"2025-10-01","currency":"USD","dateTimestamp":1759291200000,"payDate":"2025-10-07"},{"date":"2025-09-02","symbol":"DMX","amount":0.258485,"announcedDate":"2025-08-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-02","defaultRemindTime":1756819800000,"name":"DoubleLine Multi-Sector Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-08","payableDate":"2025-09-02","currency":"USD","dateTimestamp":1756785600000,"payDate":"2025-09-08"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DMX\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-23","recordDate":"2024-12-23","paymentDate":"2024-12-30","value":0.209071,"currency":"USD"},{"executeDate":"2025-02-03","recordDate":"2025-02-03","paymentDate":"2025-02-07","value":0.268541,"currency":"USD"},{"executeDate":"2025-03-03","recordDate":"2025-03-03","paymentDate":"2025-03-07","value":0.255266,"currency":"USD"},{"executeDate":"2025-04-01","recordDate":"2025-04-01","paymentDate":"2025-04-07","value":0.28018,"currency":"USD"},{"executeDate":"2025-05-01","recordDate":"2025-05-01","paymentDate":"2025-05-07","value":0.19133,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DMX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DMX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2591189988","title":"Amicus Therapeutics (FOLD) Rides DMX-200 Progress and Bullish Coverage – Is Its Pipeline Undervalued?","url":"https://stock-news.laohu8.com/highlight/detail?id=2591189988","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591189988?lang=en_us&edition=fundamental","pubTime":"2025-12-16 13:16","pubTimestamp":1765862201,"startTime":"0","endTime":"0","summary":"In recent days, Dimerix announced that its ACTION3 Phase 3 trial of DMX-200 for focal segmental glomerulosclerosis completed recruitment and dosing of 286 adult patients, while Amicus Therapeutics drew fresh attention after new analyst coverage highlighted the company’s earnings potential. \nTogether, the late-stage progress of DMX-200 and the wave of optimistic research coverage sharpen the focus on Amicus’s pipeline depth and prospects for earnings improvement. \nNow we’ll examine how this...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-fold/amicus-therapeutics/news/amicus-therapeutics-fold-rides-dmx-200-progress-and-bullish","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-fold/amicus-therapeutics/news/amicus-therapeutics-fold-rides-dmx-200-progress-and-bullish","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4097","PRGS","DMX","BK4112","LU2065732104.USD","LU2065171311.SGD","LU2065171402.SGD","LU2065170008.USD","BLSH","LU2065169927.USD","BK4139","FOLD"],"gpt_icon":0},{"id":"2579919867","title":"Dimerix Advances DMX-200 in Phase 3 Trials with Strong Financial Position","url":"https://stock-news.laohu8.com/highlight/detail?id=2579919867","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579919867?lang=en_us&edition=fundamental","pubTime":"2025-10-29 06:40","pubTimestamp":1761691234,"startTime":"0","endTime":"0","summary":"An announcement from Dimerix Limited ( ($AU:DXB) ) is now available. Dimerix Limited announced significant progress in its quarterly activities rep...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dimerix-advances-dmx-200-in-phase-3-trials-with-strong-financial-position?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dimerix-advances-dmx-200-in-phase-3-trials-with-strong-financial-position?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DMX"],"gpt_icon":0},{"id":"2571621173","title":"Dimerix’s DMX-200 Gains Orphan Drug Status in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2571621173","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571621173?lang=en_us&edition=fundamental","pubTime":"2025-09-30 08:17","pubTimestamp":1759191445,"startTime":"0","endTime":"0","summary":"Dimerix Limited ( ($AU:DXB) ) has provided an update. Dimerix Limited announced that its lead asset, DMX-200, has received Orphan Drug Designation ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dimerixs-dmx-200-gains-orphan-drug-status-in-japan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dimerixs-dmx-200-gains-orphan-drug-status-in-japan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DMX"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}]}}